Monish Jain

927 total citations
17 papers, 525 citations indexed

About

Monish Jain is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Monish Jain has authored 17 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Monish Jain's work include Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Monish Jain is often cited by papers focused on Asthma and respiratory diseases (7 papers), Respiratory and Cough-Related Research (5 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Monish Jain collaborates with scholars based in United States, Switzerland and Germany. Monish Jain's co-authors include Chul‐Hoon Kwon, Brian Ethell, Richard Zang, Ty Gould, Tove Tuntland, Keith Hoffmaster, Takatoshi Kosaka, Francesca Blasco, Xiaohong Chen and Jakal Amin and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Allergy and Clinical Immunology and Journal of Medicinal Chemistry.

In The Last Decade

Monish Jain

14 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monish Jain United States 9 181 169 66 60 58 17 525
Kavita Pal India 14 116 0.6× 89 0.5× 22 0.3× 70 1.2× 54 0.9× 34 429
Andrei W. Konradi United States 14 298 1.6× 328 1.9× 25 0.4× 63 1.1× 18 0.3× 27 754
Pierre De Clercq Belgium 15 208 1.1× 252 1.5× 44 0.7× 74 1.2× 12 0.2× 40 860
Lawrence A. Reiter United States 15 358 2.0× 268 1.6× 23 0.3× 100 1.7× 58 1.0× 32 697
Ruijuan Luo United States 10 194 1.1× 95 0.6× 40 0.6× 90 1.5× 16 0.3× 15 431
Douglas G. Batt United States 18 274 1.5× 405 2.4× 19 0.3× 92 1.5× 40 0.7× 35 803
Jinqian Liu United States 16 386 2.1× 527 3.1× 20 0.3× 91 1.5× 80 1.4× 29 1.1k
Michael W. Lago United States 10 209 1.2× 91 0.5× 12 0.2× 93 1.6× 33 0.6× 13 538
Lance Goulet United States 11 379 2.1× 58 0.3× 52 0.8× 81 1.4× 18 0.3× 14 639

Countries citing papers authored by Monish Jain

Since Specialization
Citations

This map shows the geographic impact of Monish Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monish Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monish Jain more than expected).

Fields of papers citing papers by Monish Jain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monish Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monish Jain. The network helps show where Monish Jain may publish in the future.

Co-authorship network of co-authors of Monish Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Monish Jain. A scholar is included among the top collaborators of Monish Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monish Jain. Monish Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Gauvreau, Gail M., Jens M. Hohlfeld, J. Mark FitzGerald, et al.. (2023). Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma. European Respiratory Journal. 61(3). 2201193–2201193. 40 indexed citations
3.
4.
Jain, Monish, et al.. (2022). Topical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants. Translational Vision Science & Technology. 11(11). 15–15. 8 indexed citations
5.
Buhl, Roland, Hanns-Christian Tillmann, Soniya Vaidya, et al.. (2021). Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma. Pulmonary Pharmacology & Therapeutics. 70. 102068–102068. 7 indexed citations
6.
Bartels, Christian, Monish Jain, Jing Yu, Hanns-Christian Tillmann, & Soniya Vaidya. (2021). Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with Asthma. European Journal of Drug Metabolism and Pharmacokinetics. 46(4). 487–504. 2 indexed citations
7.
8.
Gauvreau, Gail M., Jens M. Hohlfeld, Louis‐Philippe Boulet, et al.. (2020). Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients. 3690–3690. 11 indexed citations
9.
Nakajima, Katsumasa, J.T. Brewer, Thomas Daniels, et al.. (2016). Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(4). 1245–1248. 5 indexed citations
10.
Tuntland, Tove, Brian Ethell, Takatoshi Kosaka, et al.. (2014). Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research. Frontiers in Pharmacology. 5. 174–174. 152 indexed citations
11.
Barnes‐Seeman, David, Monish Jain, Suzie A. Ferreira, et al.. (2013). Metabolically Stable tert -Butyl Replacement. ACS Medicinal Chemistry Letters. 4(6). 514–516. 102 indexed citations
12.
Serrano‐Wu, Michael H., Gary M. Coppola, Alan D. Neubert, et al.. (2012). Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides. ACS Medicinal Chemistry Letters. 3(5). 411–415. 20 indexed citations
13.
Kwak, Young‐Shin, Gary M. Coppola, Cornelia J. Forster, et al.. (2011). A new structural alert for benzimidazoles: 2,6-Dimethylphenyl substituents increase mutagenic potential and time-dependent CYP3A4 inhibition risk. Bioorganic & Medicinal Chemistry Letters. 21(5). 1422–1424.
14.
Ziegler, David S., Renee D. Wright, Santosh Kesari, et al.. (2008). Resistance of human glioblastoma multiforme cells to growth factor inhibitors is overcome by blockade of inhibitor of apoptosis proteins. Journal of Clinical Investigation. 118(9). 3109–3122. 80 indexed citations
15.
Jain, Monish, et al.. (2004). Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study.. PubMed. 102(1). 48–50, 52. 11 indexed citations
16.
Jain, Monish, et al.. (2004). Sulfonyl-Containing Aldophosphamide Analogues as Novel Anticancer Prodrugs Targeted against Cyclophosphamide-Resistant Tumor Cell Lines. Journal of Medicinal Chemistry. 47(15). 3843–3852. 24 indexed citations
17.
Jain, Monish & Chul‐Hoon Kwon. (2003). 1,2-Benzisoxazole Phosphorodiamidates as Novel Anticancer Prodrugs Requiring Bioreductive Activation. Journal of Medicinal Chemistry. 46(25). 5428–5436. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kavita Pal Breakdown of academic impact, for papers by Andrei W. Konradi Breakdown of academic impact, for papers by Pierre De Clercq Breakdown of academic impact, for papers by Lawrence A. Reiter Breakdown of academic impact, for papers by Ruijuan Luo Breakdown of academic impact, for papers by Douglas G. Batt Breakdown of academic impact, for papers by Jinqian Liu Breakdown of academic impact, for papers by Michael W. Lago Breakdown of academic impact, for papers by Lance Goulet
Rankless by CCL
2026